RSS

Experimental Drug for RRMS, SPMS Enters Phase 2 Trial #MS #progressiveMS

25 Nov

Read more about Dosing Completed in 1st Cohort in MyeloXen Phase 2 Trial for RRSP MS, care of Xenetic Biosciences partner, Pharmasynthez.

Source: multiplesclerosisnewstoday.com

See on Scoop.itOvercoming Multiple Sclerosis

Advertisements
 
Leave a comment

Posted by on 25 November 2014 in Uncategorized

 

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

 
%d bloggers like this: